Slovenia to get Japanese drug for trials on Covid-19 patients
Ljubljana, 15 May - The government has accept an initiative to close an agreement with the UN Office for Project Services on the delivery of the Japanese anti-influenza medicine called favipiravir for clinical trials in treatment of Covid-19 patients.
The rest of this news item is available to subscribers.
The news item consists of 1.561 characters (without spaces) or 293 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.